SR ONE CAPITAL MANAGEMENT, LP
REDWOOD CITY, CA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$1.15B2026 Q3
Positions17
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.94.0%
What Changed This Quarter?
Top Holdings
MANE
Veradermics
21.9%
ADRX
ADARx Pharmaceuticals
17.2%
ZBIO
Zenas BioPharma
11.8%
CRSP
CRISPR Therapeutics
9.8%
AVLN
Avalyn Pharma
8.2%
ODTX
Odyssey Therapeutics
7.3%
DSGN
Design Therapeutics
7.1%
ORIC
Oric Pharmaceuticals
5.4%
New / Increased
3 new · 0 increased
ADRXNEW
ADARx Pharmaceuticals
17.2%
KRSANEW
Korsana Biosciences
1.7%
ENGNNEW
enGene Therapeutics
0.1%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.